Clinical Trials Sponsored by Kernan Hospital, Baltimore

Total 900 results

Sinai Hospital of Baltimore

Unknown

Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls

Neoplasm

United States
Sinai Hospital of Baltimore

Unknown

Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

Ovarian Cancer | Endometrial Cancer

United States
Sinai Hospital of Baltimore
Bonutti Clinic

Completed

A Comparison of Subvastus and Midvastus Approaches in Minimally-Invasive Total Knee Arthroplasty

Total Knee Arthroplasty

United States
Kerman Medical University
Afzalipour Hospital

Not yet recruiting

Efficacy of NOSHINtrial in Diabetic Patients (NOSHIN)

Diabetes Mellitus, Type 2 | Insulin Resistance

Iran, Islamic Republic of
University of Maryland, Baltimore
Children's Hospital of Philadelphia

Withdrawn

Growth Hormone for Osteoporosis Pseudoglioma Syndrome (GHOPPG)

Osteoporosis Pseudoglioma Syndrome

United States
University of Maryland, Baltimore
Northwestern University; Northwestern Memorial Hospital

Recruiting

Sensory-Motor Rehabilitation Post Stroke

Acute Stroke

United States
University of Maryland, Baltimore
Beaujon Hospital; University Grenoble Alps

Completed

Prehospital Norepinephrine and Early Mortality in Traumatic Shock

Traumatic Brain Injury | Hemorrhagic Shock | Hypotension and Shock | Traumatic Shock
Henan Cancer Hospital

Recruiting

Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure

Non-Squamous Non-Small Cell Lung Cancer

China
Henan Cancer Hospital

Recruiting

The Maintenance Treatment of "ITIVA" in AML Patients

Acute Myeloid Leukemia | Thalidomide | Maintenance Treatment | Minor Residue Disease | Interferon-α-1b | Interleukin-2 | Venentoclax | Azacitidine

China
Henan Cancer Hospital

Not yet recruiting

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial

Advanced Breast Cancer | Treatment | HR Low/HER2 Negative
Henan Cancer Hospital

Recruiting

Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC

Breast Cancer | HER2-positive Breast Cancer

China
Henan Cancer Hospital

Recruiting

Lenvatinib for Advanced Bone and Soft Tissue Sarcoma

Sexuality | Effectiveness

China
Henan Cancer Hospital

Not yet recruiting

Application of LARS Ligament in Bone Prosthesis Replacement

Malignant Tumor

China
Henan Cancer Hospital

Not yet recruiting

Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence

Hepatocellular Carcinoma
Henan Cancer Hospital

Recruiting

Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor

Desmoid

China
Henan Cancer Hospital

Recruiting

Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors

Clinical Features | Bone and Soft Tissue Tumors

China
Henan Cancer Hospital

Recruiting

PD-1 Antibody Tislelizumab Combined With Dacarbazine in the Treatment of Advanced Melanoma

Advanced Melanoma

China
Henan Cancer Hospital

Recruiting

Study on Clinical Features, Treatment Mode and Survival of Sarcoma

Sarcoma

China
Henan Cancer Hospital

Recruiting

Utidelone in Third-line and Above Treatment of Small Cell Lung Cancer

SCLC, Extensive Stage

China
Henan Cancer Hospital

Not yet recruiting

PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma. (SCRCA)

Cholangiocarcinoma
Henan Cancer Hospital

Recruiting

Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.

Soft Tissue Sarcoma

China
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma

Advanced Gastric Carcinoma

China
Henan Cancer Hospital

Recruiting

Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma

Central Nervous System Lymphoma

China
Henan Cancer Hospital

Recruiting

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

Marginal Zone Lymphoma

China
Henan Cancer Hospital

Recruiting

Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma

Lymphoma | Gene Abnormality

China
Henan Cancer Hospital

Recruiting

Study of CT and MR in the Gastric Cancer

MRI | Neoadjuvant Therapy | Gastric Cancer Stage | CT

China
Henan Cancer Hospital

Recruiting

Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer

Esophageal Cancer | Squamous Cell Carcinoma | Perioperative Period

China
Henan Cancer Hospital

Recruiting

The Application of 3T MRI in Esophageal Cancer

Magnetic Resonance Imaging | Prognosis | Esophageal Cancer TNM Staging

China
Henan Cancer Hospital

Completed

Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC

Triple Negative Breast Cancer

China
Henan Cancer Hospital

Active, not recruiting

SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma

Gastric Cancer

China
Henan Cancer Hospital

Active, not recruiting

Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Henan Cancer Hospital

Active, not recruiting

Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma

Gastric Cancer

China
Henan Cancer Hospital

Unknown

S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC

Advanced NSCLC With EGFR Mutation

China
Henan Cancer Hospital

Terminated

Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer

Advanced Cancer

China
Henan Cancer Hospital

Unknown

SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer

Triple-negative Breast Cancer
Henan Cancer Hospital

Unknown

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Advanced Cancer | Mucosal Melanoma | Apatinib | SHR-1210

China
Henan Cancer Hospital

Unknown

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

Gastrointestinal Neuroendocrine Tumor
Henan Cancer Hospital

Unknown

Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer

Advanced Gastric Cancer
Henan Cancer Hospital

Unknown

The FLOT Regimen Conversion Therapy of Adenocarcinoma of the Stomach / Gastroesophageal

Adenocarcinoma of the Stomach / Gastroesophageal

China
Saudi German Hospital - Madinah

Completed

Nonsurgical Management of Cesarean Scar Niche Related Abnormal Uterine Bleeding

Intermenstrual Bleeding

Saudi Arabia
Saudi German Hospital - Madinah

Completed

Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate Resistance

Polycystic Ovarian Syndrome

Saudi Arabia
Henan Cancer Hospital

Not yet recruiting

PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer

Metastatic Colon Cancer
Henan Cancer Hospital

Recruiting

TAS-102 Combined With Bevacizumab for Second-line Maintenance Treatment of Advanced Colorectal Cancer

Colorectal Cancer

China
Henan Cancer Hospital

Recruiting

Go-CHOP as the Frontline Therapy for PTCL

Peripheral T Cell Lymphoma

China
Henan Cancer Hospital

Recruiting

A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer

HER2 Low Breast Carcinoma

China
Henan Cancer Hospital

Recruiting

Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin

Squamous Cell Carcinoma of the Skin

China
Henan Cancer Hospital

Recruiting

Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma

Soft Tissue Sarcoma

China
Henan Cancer Hospital

Not yet recruiting

Application of Antiosteoporosis Therapy in Osteolysis

Complication | Limb; Fusion

China
Henan Cancer Hospital

Not yet recruiting

Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes

Gastric Cancer | Gastroesophageal-junction Cancer
Henan Cancer Hospital

Not yet recruiting

Application of Douyin in Perioperative Period of Malignant Tumor Patients

Perioperative Period | Malignant Tumor of Bone

3

Subscribe